AQR Arbitrage’s 4D Pharma PLC Warrant LBPSW Stock Holding History

AQR Arbitrage’s Portfolio LBPSW Stock Details LBPSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-55,653	Closed	-$2K	–	1591
2022 Q2	$2K	Sell	55,653 -7,373	-12%	-$1.99K	﹤0.01%	1489
2022 Q1	$25K	Buy	63,026 +27,173	+76%	+$11.3K	﹤0.01%	1079
2021 Q4	$2.6M	Sell	35,853 -41,713	-54%	-$28.9K	0.07%	318
2021 Q3	$54K	Sell	77,566 -12,083	-13%	-$11.4K	﹤0.01%	904
2021 Q2	$88K	Sell	89,649 -35,351	-28%	-$35.6K	﹤0.01%	859
2021 Q1	$136K	Buy	+125,000	New	+$156K	﹤0.01%	815

AQR Arbitrage's LBPSW Position: Q3 2022 in Review

AQR Arbitrage sold out of 4D Pharma PLC Warrant (LBPSW) in Q3 2022, closing a stake of 55,653 shares — an estimated $2K sold.

AQR Arbitrage first reported a position in LBPSW in Q1 2021 and held it in 6 quarters. The position peaked at $2.6M in Q4 2021. 0 funds tracked by Wall St. Rank hold LBPSW as of Q3 2022.

AQR Arbitrage reported no remaining 4D Pharma PLC Warrant position as of Q3 2022 after selling out during the quarter.
AQR Arbitrage sold 55,653 4D Pharma PLC Warrant shares in Q3 2022, an estimated $2K.
AQR Arbitrage first reported a position in 4D Pharma PLC Warrant in Q1 2021 and held it in 6 quarters.
AQR Arbitrage's 4D Pharma PLC Warrant position peaked at $2.6M in Q4 2021.
0 funds tracked by Wall St. Rank held 4D Pharma PLC Warrant as of Q3 2022.

Based on AQR Arbitrage's 13F filing for Q3 2022, filed 14 Nov 2022.